Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 48 | 53 | 41 | -3 | 197 |
| Accounts receivable | -98 | -478 | 16 | 85 | -134 |
| Accounts payable and accrued liabilities | -287 | 363 | -6,577 | N/A | N/A |
| Other Working Capital | -1,115 | 3,848 | -9,293 | 3,489 | 1,201 |
| Other Operating Activity | -12,536 | -15,266 | -1,266 | -8,763 | -5,397 |
| Operating Cash Flow | $-13,988 | $-11,480 | $-17,079 | $-5,192 | $-4,133 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 7 | -273 | -54 | 0 | 0 |
| Purchase Of Investment | -76,690 | -90,767 | -13 | N/A | N/A |
| Sale Of Investment | 13,953 | 23,652 | 15,831 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 11,522 | 2,878 |
| Investing Cash Flow | $-62,730 | $-67,388 | $15,764 | $11,522 | $2,878 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | 277 | -73 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 165,311 |
| Other Financing Activity | 112 | 895 | 1,631 | 3,506 | 382 |
| Financing Cash Flow | $112 | $895 | $1,631 | $3,783 | $165,620 |
| Exchange Rate Effect | -6 | -93 | -11 | 227 | 26 |
| Beginning Cash Position | 169,839 | 247,905 | 247,600 | 237,260 | 72,869 |
| End Cash Position | 93,227 | 169,839 | 247,905 | 247,600 | 237,260 |
| Net Cash Flow | $-76,606 | $-77,973 | $316 | $10,113 | $164,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,988 | -11,480 | -17,079 | -5,192 | -4,133 |
| Capital Expenditure | N/A | -273 | -54 | N/A | N/A |
| Free Cash Flow | -13,988 | -11,753 | -17,133 | -5,192 | -4,133 |